115 related articles for article (PubMed ID: 17614731)
1. Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosis.
Wang HW; Finlay JC; Lee K; Zhu TC; Putt ME; Glatstein E; Koch CJ; Evans SM; Hahn SM; Busch TM; Yodh AG
J Biomed Opt; 2007; 12(3):034023. PubMed ID: 17614731
[TBL] [Abstract][Full Text] [Related]
2. In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates.
Solonenko M; Cheung R; Busch TM; Kachur A; Griffin GM; Vulcan T; Zhu TC; Wang HW; Hahn SM; Yodh AG
Phys Med Biol; 2002 Mar; 47(6):857-73. PubMed ID: 11936174
[TBL] [Abstract][Full Text] [Related]
3. In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors.
Mahy P; De Bast M; Gallez B; Gueulette J; Koch CJ; Scalliet P; Grégoire V
Radiother Oncol; 2003 Apr; 67(1):53-61. PubMed ID: 12758240
[TBL] [Abstract][Full Text] [Related]
4. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.
Zhu TC; Finlay JC; Hahn SM
J Photochem Photobiol B; 2005 Jun; 79(3):231-41. PubMed ID: 15896650
[TBL] [Abstract][Full Text] [Related]
5. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
6. Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy.
Finlay JC; Zhu TC; Dimofte A; Stripp D; Malkowicz SB; Busch TM; Hahn SM
Photochem Photobiol; 2006; 82(5):1270-8. PubMed ID: 16808592
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
8. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
[TBL] [Abstract][Full Text] [Related]
9. Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light.
Yu G; Durduran T; Zhou C; Zhu TC; Finlay JC; Busch TM; Malkowicz SB; Hahn SM; Yodh AG
Photochem Photobiol; 2006; 82(5):1279-84. PubMed ID: 16696593
[TBL] [Abstract][Full Text] [Related]
10. Spatial heterogeneity and temporal kinetics of photosensitizer (AlPcS2) concentration in murine tumors RIF-1 and MTG-B.
Lee CC; Pogue BW; O'Hara JA; Wilmot CM; Strawbridge RR; Burke GC; Hoopes PJ
Photochem Photobiol Sci; 2003 Feb; 2(2):145-50. PubMed ID: 12664976
[TBL] [Abstract][Full Text] [Related]
11. Effects of hyperglycemia on oxygenation, radiosensitivity and bioenergetic status of subcutaneous RIF-1 tumors.
Nadal-Desbarats L; Poptani H; Oprysko P; Jenkins WT; Busch TM; Nelson DS; Glickson JD; Koch CJ; Evans SM
Int J Oncol; 2002 Jul; 21(1):103-10. PubMed ID: 12063556
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cells.
Chen Z; Woodburn KW; Shi C; Adelman DC; Rogers C; Simon DI
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):759-64. PubMed ID: 11348871
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog.
Ross HM; Smelstoys JA; Davis GJ; Kapatkin AS; Del Piero F; Reineke E; Wang H; Zhu TC; Busch TM; Yodh AG; Hahn SM
J Surg Res; 2006 Oct; 135(2):323-30. PubMed ID: 16650871
[TBL] [Abstract][Full Text] [Related]
14.
Finlay JC; Zhu TC; Dimofte A; Stripp D; Malkowicz SB; Whittington R; Miles J; Glatstein E; Hahn SM
Proc SPIE Int Soc Opt Eng; 2014 Jun; 5315():132-142. PubMed ID: 26146442
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
16. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo.
McSheehy PM; Robinson SP; Ojugo AS; Aboagye EO; Cannell MB; Leach MO; Judson IR; Griffiths JR
Cancer Res; 1998 Mar; 58(6):1185-94. PubMed ID: 9515804
[TBL] [Abstract][Full Text] [Related]
17. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].
Busch TM; Hahn SM; Evans SM; Koch CJ
Cancer Res; 2000 May; 60(10):2636-42. PubMed ID: 10825135
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients.
Busch TM; Hahn SM; Wileyto EP; Koch CJ; Fraker DL; Zhang P; Putt M; Gleason K; Shin DB; Emanuele MJ; Jenkins K; Glatstein E; Evans SM
Clin Cancer Res; 2004 Jul; 10(14):4630-8. PubMed ID: 15269134
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of changes in tumor oxygenation during growth and after treatment.
Bratasz A; Pandian RP; Deng Y; Petryakov S; Grecula JC; Gupta N; Kuppusamy P
Magn Reson Med; 2007 May; 57(5):950-9. PubMed ID: 17457861
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model.
Griffin GM; Zhu T; Solonenko M; Del Piero F; Kapakin A; Busch TM; Yodh A; Polin G; Bauer T; Fraker D; Hahn SM
Clin Cancer Res; 2001 Feb; 7(2):374-81. PubMed ID: 11234893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
